Return to Vaccines Alert Section
Reports from University of North Carolina describe recent advances in cancer vaccines
April 7th, 2008
2008 APR 7 -- New investigation results, 'Influence of parent characteristics and disease outcome framing on HPV vaccine acceptability among rural, Southern women,' are detailed in a study published in Cancer Causes and Control. "A new prophylactic vaccine protects against infection with HPV types that cause many cervical cancers and genital warts. This study explored the impact of framing the vaccine's benefits, with respect to the disease outcome being prevented, on women's HPV vaccination intentions for themselves and for an adolescent daughter," scientists in the United States report. "A cross-sectional study was conducted in a rural North Carolina area with a high cervical cancer mortality rate. A questionnaire was administered among female attendees of a low-income public clinic and a private OB/GYN office. Data were analyzed using a generalized estimable model. Women reported high intentions to vaccinate against HPV. Women reported higher intentions to vaccinate adolescent daughters than themselves, and this relationship varied by how the HPV vaccine was framed (preventing HPV, cervical cancer, or genital warts). Older women reported lower vaccination intentions than younger women. Rural women, especially those who are younger, may be more accepting of the HPV vaccine when it is framed as a cervical cancer vaccine," wrote N.R. Sperber and colleagues, University of North Carolina. The researchers concluded: "Messages to mothers about the HPV vaccine for their daughters might be made more effective by framing the vaccine in terms of cancer and sexually transmitted disease prevention." Sperber and colleagues published their study in Cancer Causes and Control (Influence of parent characteristics and disease outcome framing on HPV vaccine acceptability among rural, Southern women. Cancer Causes and Control, 2008;19(1):115-8). For more information, contact N.R. Sperber, University of North Carolina, University of North Carolina, Dept. of Health Behavior and Health Education, Chapel Hill, NC 27599-7400 USA.. Publisher contact information for the journal Cancer Causes and Control is: Kluwer Academic Publ, Van Godewijckstraat 30, 3311 Gz Dordrecht, Netherlands. Keywords: United States, Chapel Hill, Adolescent Medicine, Biotechnology, Cancer Vaccines, Cervical Cancer, Cervical Carcinoma, Dermatology, Genital Warts, HPV Vaccines, Human Papillomavirus Vaccines, Immunization, Oncology, Prophylactic Vaccines, Prophylaxis, Urology, Vaccination, Women's Health. This article was prepared by Clinical Oncology Week editors from staff and other reports. Copyright 2008, Clinical Oncology Week via NewsRx.com.
Return to Vaccines Alert Section
|
